Top 10 Books about Stock Investing to read in 2018. Read more.

AMED - Amedisys Inc

Industry: Home Health Care Sector: Healthcare Exchange: NASDAQ

AMED - Amedisys Inc

Industry: Home Health Care Sector: Healthcare Exchange: NASDAQ

Thu 22'nd Mar 2018

PERIOD 2017-12-26 - 2018-03-22
CHANGE -0.05%
PRICE $61.40





Request Prediction

Amedisys Inc Stock Analysis

Technical stock analysis for Thu 22'nd Mar 2018

Hold candidate since 2018-03-22

Amedisys Inc fell by -0.05% in the last day from $61.43 to $61.40 and has now fallen 4 days in a row. The price has risen in 5 of the last 10 days and is up by 2.4% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -44 308 shares and in total 124 962 shares bought and sold for approximately $7.67 million.

Shorts 7.57% ( 2018-02-28 )
Cash 173.6 mill
Loans 273.6 mill
Beta 0.62
ROA 3.92


Amedisys Inc lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.99% during the next 3 months and, with 90% probability hold a price between $66.24 and $76.37 at the end of this period.

Click here for today's Top 5 Trending Companies


Amedisys Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $61.98. On a fall, the stock will find some support from the long-term average at approximately $58.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Monday March 19, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 74 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Amedisys Inc finds support from accumulated volume at $59.21. On the upside the stock meets some resistance just above today's level from accumulated volume at $61.46, $61.60 and $62.73.

The stock is about to test the resistance from accumulated volume at $61.46 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $59.21 Price: $61.40 Resistance: $61.46


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $2.84 (4.75%) between high and low. For the last week, the stock has had a daily average volatility of 3.08%.

Our recommended stoploss: $58.57 (-4.61%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 74 and this increases the risk substantially. There is a sell signal from pivot top found 3 days ago.)

Overall risk:

Very Low Low Medium High Very High


Amedisys Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.

Trade AMED CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features